SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,821,000 | -19.3% | 2,938,494 | 0.0% | 0.11% | +29.3% |
| Q1 2022 | $3,497,000 | -63.5% | 2,938,494 | 0.0% | 0.08% | -44.6% |
| Q4 2021 | $9,579,000 | -27.1% | 2,938,494 | 0.0% | 0.15% | +7.2% |
| Q3 2021 | $13,135,000 | -18.0% | 2,938,494 | 0.0% | 0.14% | -32.7% |
| Q2 2021 | $16,015,000 | -27.1% | 2,938,494 | 0.0% | 0.20% | -41.8% |
| Q1 2021 | $21,980,000 | -31.1% | 2,938,494 | 0.0% | 0.35% | -39.3% |
| Q4 2020 | $31,883,000 | +22.7% | 2,938,494 | 0.0% | 0.58% | -19.2% |
| Q3 2020 | $25,976,000 | -17.1% | 2,938,494 | 0.0% | 0.72% | -21.1% |
| Q2 2020 | $31,324,000 | +79.8% | 2,938,494 | 0.0% | 0.91% | +11.4% |
| Q1 2020 | $17,425,000 | -14.2% | 2,938,494 | 0.0% | 0.82% | -28.0% |
| Q4 2019 | $20,305,000 | -33.4% | 2,938,494 | 0.0% | 1.14% | -32.0% |
| Q3 2019 | $30,502,000 | +2.8% | 2,938,494 | -8.3% | 1.67% | +30.0% |
| Q2 2019 | $29,673,000 | +1.3% | 3,204,437 | 0.0% | 1.28% | +15.9% |
| Q1 2019 | $29,289,000 | +64.1% | 3,204,437 | 0.0% | 1.11% | +27.1% |
| Q4 2018 | $17,849,000 | -53.2% | 3,204,437 | 0.0% | 0.87% | -65.4% |
| Q3 2018 | $38,165,000 | +16.7% | 3,204,437 | 0.0% | 2.52% | -59.8% |
| Q2 2018 | $32,717,000 | -21.3% | 3,204,437 | 0.0% | 6.27% | -48.0% |
| Q1 2018 | $41,594,000 | +33.4% | 3,204,437 | 0.0% | 12.06% | +52.5% |
| Q4 2017 | $31,179,000 | -33.9% | 3,204,437 | 0.0% | 7.91% | -49.9% |
| Q3 2017 | $47,169,000 | -39.0% | 3,204,437 | -33.3% | 15.78% | -42.2% |
| Q2 2017 | $77,339,000 | +1.0% | 4,806,656 | 0.0% | 27.27% | +34.0% |
| Q1 2017 | $76,570,000 | +31.0% | 4,806,656 | 0.0% | 20.35% | +7.0% |
| Q4 2016 | $58,449,000 | -12.3% | 4,806,656 | 0.0% | 19.02% | +4.4% |
| Q3 2016 | $66,668,000 | – | 4,806,656 | – | 18.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|